Bayesian integration G-formula for platform SMART designs allowing for adding new treatments
Fuente:
arXiv
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Preprint |
| Veröffentlicht: |
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866911628017008640 |
|---|---|
| author | Wang, Xinru Bose, Meghna Chakraborty, Bibhas Mahar, Robert |
| author_facet | Wang, Xinru Bose, Meghna Chakraborty, Bibhas Mahar, Robert |
| contents | Dynamic treatment regimes (DTRs) are sequences of decision rules to guide treatment assignments in response to a patient's evolving, time-varying disease status. Sequential multiple assignment randomized trials (SMARTs) are considered the gold standard experimental design for evaluating DTRs. However, SMARTs often require more time to complete compared with a single stage RCT and new candidate treatments may become available or feasible during the trial. Platform trials are an adaptive trial design that allow new treatments to be added to the ongoing study according to a prespecified master protocol. In this paper, we introduce a novel platform SMART that integrates features from both platform trials and SMARTs, allowing new treatments to be added during the trial. Additionally, we propose the Bayesian integration G-formula (BIG) estimators for platform SMARTs to account for non-concurrent treatment comparisons. Extensive simulations are conducted to evaluate the performance of different BIG estimators against benchmark methods. We demonstrate the proposed BIG estimators based on the S. aureus Network Adaptive Platform (SNAP) trial. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2604_25252 |
| institution | arXiv |
| publishDate | 2026 |
| record_format | arxiv |
| spellingShingle | Bayesian integration G-formula for platform SMART designs allowing for adding new treatments Wang, Xinru Bose, Meghna Chakraborty, Bibhas Mahar, Robert Methodology Dynamic treatment regimes (DTRs) are sequences of decision rules to guide treatment assignments in response to a patient's evolving, time-varying disease status. Sequential multiple assignment randomized trials (SMARTs) are considered the gold standard experimental design for evaluating DTRs. However, SMARTs often require more time to complete compared with a single stage RCT and new candidate treatments may become available or feasible during the trial. Platform trials are an adaptive trial design that allow new treatments to be added to the ongoing study according to a prespecified master protocol. In this paper, we introduce a novel platform SMART that integrates features from both platform trials and SMARTs, allowing new treatments to be added during the trial. Additionally, we propose the Bayesian integration G-formula (BIG) estimators for platform SMARTs to account for non-concurrent treatment comparisons. Extensive simulations are conducted to evaluate the performance of different BIG estimators against benchmark methods. We demonstrate the proposed BIG estimators based on the S. aureus Network Adaptive Platform (SNAP) trial. |
| title | Bayesian integration G-formula for platform SMART designs allowing for adding new treatments |
| topic | Methodology |
| url | https://arxiv.org/abs/2604.25252 |